Biljak Vanja Radišić, Aakre Kristin Moberg, Yucel Dogan, Bargnoux Anne-Sophie, Cristol Jean-Paul, Piéroni Laurence
Department of Medical Biochemistry and Laboratory Medicine, Merkur University Hospital, Zagreb, Croatia, on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine (CSMBLM).
Laboratory of Clinical Biochemistry, Haukeland University Hospital, Bergen, Norway.
EJIFCC. 2017 Dec 19;28(4):289-301. eCollection 2017 Dec.
The principal benefit of guidelines is to improve the quality of care received by patients. In the 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (KDIGO) was released and it is designed to provide information and assist decision making. This review gives a brief overview of a various national CKD guidelines that rely on the newly released KDIGO guidelines. All of the included countries (France, Turkey, Norway and Croatia) are non-English speaking countries and they differ in population and socio economic aspects. Examples shown in this review may provide valuable experience for countries that are in process of creating their national CKD guidelines.
指南的主要益处在于提高患者所接受的医疗服务质量。2012年发布了《慢性肾脏病评估与管理临床实践指南》(KDIGO),其旨在提供信息并协助决策。本综述简要概述了各种依赖新发布的KDIGO指南的国家慢性肾脏病指南。所有纳入的国家(法国、土耳其、挪威和克罗地亚)均为非英语国家,且在人口和社会经济方面存在差异。本综述中展示的实例可能为正在制定本国慢性肾脏病指南的国家提供宝贵经验。